Oral Medicine| Volume 93, ISSUE 1, P45-55, January 2002

Differences in risk factors among clinical types of oral candidiasis in the Women's Interagency HIV Study


      Objectives: The purpose of this study was to determine the prevalence and concurrence/associations of oral candidiasis types and multiple risk factors in women. Study Design: A cross-sectional analysis of baseline data for 577 human immunodeficiency virus (HIV)–seropositive and 152 HIV-seronegative women from the Women's Interagency HIV Study was conducted. Pseudomembranous candidiasis (PC) and erythematous (EC) candidiasis, angular cheilitis (AC), and denture stomatitis (DS) were studied, and bivariate and multivariate regression analyses were performed. Results: Prevalences were 8% for PC, 7% for EC, 18% for DS, and 3% for AC; all except AC usually occurred alone. HIV seropositivity was associated with PC, EC, and DS, but not AC. Among HIV-seropositive women, low CD4 cell counts were associated with PC, but not with EC or DS. Heroin/methadone use was associated with PC and EC; salivary hypofunction was associated with PC; high viral load was associated with EC, and poor oral hygiene, with EC and DS. Conclusions: Risk factors varied among candidiasis types, suggesting differences in pathogenic mechanisms and usefulness as markers of HIV infection/progression. (Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002;93:45-55)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


        • Crockett DN
        • O'Grady JF
        • Reade PC
        Candida species and Candida albicans morphotypes in erythematous candidiasis.
        Oral Surg Oral Med Oral Pathol. 1992; 73: 559-563
        • MacPhail LA
        • Hilton JF
        • Dodd CL
        • Greenspan D.
        Prophylaxis with nystatin pastilles for HIV-associated oral candidiasis.
        J Acquir Immune Defic Syndr Hum Retrovirol. 1996; 12: 470-476
        • Sullivan D
        • Coleman D.
        Candida dubliniensis : an emerging opportunistic pathogen.
        Curr Top Med Mycol. 1997; 8: 15-25
        • Greenspan JS
        • Barr CE
        • Sciubba JJ
        • Winkler JR.
        Oral manifestations of HIV infection. Definitions, diagnostic criteria, and principles of therapy. The U.S.A. Oral AIDS Collaborative Group.
        Oral Surg Oral Med Oral Pathol. 1992; 73: 142-144
      1. J Oral Pathol Med. 1993; 22: 289-291
        • Klein RS
        • Harris CA
        • Small CB
        • Moll B
        • Lesser M
        • Friedland GH.
        Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome.
        N Engl J Med. 1984; 311: 354-358
        • Dodd CL
        • Greenspan D
        • Katz MH
        • Westenhouse JL
        • Feigal DW
        • Greenspan JS.
        Oral candidiasis in HIV infection: pseudomembranous and erythematous candidiasis show similar rates of progression to AIDS.
        AIDS. 1991; 5: 1339-1343
        • Patton LL.
        Sensitivity, specificity, and positive predictive value of oral opportunistic infections in adults with HIV/AIDS as markers of immune suppression and viral burden.
        Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000; 90: 182-188
        • Barkan SE
        • Melnick SL
        • Preston-Martin S
        • Weber K
        • Kalish LA
        • Miotti P
        • et al.
        The Women's Interagency HIV Study. WIHS Collaborative Study Group.
        Epidemiology. 1998; 9: 117-125
        • Dajani AS
        • Bisno AL
        • Chung KJ
        • Durack DT
        • Freed M
        • Gerber MA
        • et al.
        Prevention of bacterial endocarditis.
        JAMA. 1990; 264: 2919-2922
        • Regezi JA
        • Sciubba JJ.
        Oral pathology: clinical pathologic correlations.
        in: : Saunders, Philadelphia1999: 107-113
        • Budtz-Jorgensen E.
        Denture stomatitis. 3. Histopathology of trauma—and Candida -induced inflammatory lesions of the palatal mucosa.
        Acta Odontol Scand. 1970; 28: 551-579
        • Knight L
        • Fletcher J.
        Growth of Candida albicans in saliva: stimulation by glucose associated with antibiotics, cortico-steroids, and diabetes mellitus.
        J Infect Dis. 1971; 123: 371-377
        • McCarthy GM.
        Host factors associated with HIV-related oral candidiasis.
        A review. Oral Surg Oral Med Oral Pathol. 1992; 73: 181-186
        • Lucas VS.
        Association of psychotropic drugs, prevalence of denture-related stomatitis and oral candidosis.
        Community Dent Oral Epidemiol. 1993; 21: 313-316
      2. MMWR. 1995; 44: 1-34
        • Carlos J
        • Brunelle J.
        Oral health surveys of the National Institute of Dental Research: diagnostic criteria and procedures. Vol. 91-2870. : NIH, Bethesda1991: 1-99
        • Silness J
        • Löe H.
        Periodontal disease in pregnancy. 3. Response to local treatment.
        Acta Odontol Scand. 1966; 24: 747-759
        • Swango PA
        • Kleinman DV
        • Konzelman JL.
        HIV and periodontal health. A study of military personnel with HIV.
        J Am Dent Assoc. 1991; 122: 49-54
      3. MMWR. 1998; 47: 43-82
      4. SAS/SAT user's guide. 4th ed. : SAS Institute Inc, Cary, NC1989
        • Shiboski CH.
        Epidemiology of HIV-related oral manifestations in women: a review.
        Oral Dis. 1997; 3: S18-S27
        • Greenspan D
        • Komaroff E
        • Redford M
        • Phelan JA
        • Navazesh M
        • Alves ME
        • et al.
        Oral mucosal lesions and HIV viral load in the Women's Interagency HIV Study (WIHS).
        J Acquir Immune Defic Syndr. 2000; 25: 44-50
        • Schuman P
        • Ohmit SE
        • Sobel JD
        • Mayer KH
        • Greene V
        • Rompalo A
        • et al.
        Oral lesions among women living with or at risk for HIV infection. HIV Epidemiology Research Study (HERS) Group.
        Am J Med. 1998; 104: 559-564
        • Martins MD
        • Lozano-Chiu M
        • Rex JH.
        Declining rates of oropharyngeal candidiasis and carriage of Candida albicans associated with trends toward reduced rates of carriage of fluconazole-resistant C. albicans in human immunodeficiency virus–infected patients.
        Clin Infect Dis. 1998; 27: 1291-1294
        • Cauda R
        • Tacconelli E
        • Tumbarello M
        • Morace G
        • De Bernardis F
        • Torosantucci A
        • et al.
        Role of protease inhibitors in preventing recurrent oral candidosis in patients with HIV infection: a prospective case-control study.
        J Acquir Immune Defic Syndr. 1999; 21: 20-25
        • Diz Dios P
        • Ocampo A
        • Miralles C
        • Otero I
        • Iglesias I
        • Rayo N.
        Frequency of oropharyngeal candidiasis in HIV-infected patients on protease inhibitor therapy.
        Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999; 87: 437-441
        • Govitrapong P
        • Suttitum T
        • Kotchabhakdi N
        • Uneklabh T.
        Alterations of immune functions in heroin addicts and heroin withdrawal subjects.
        J Pharmacol Exp Ther. 1998; 286: 883-889
        • McCarthy GM
        • Mackie ID
        • Koval J
        • Sandhu HS
        • Daley TD.
        Factors associated with increased frequency of HIV-related oral candidiasis.
        J Oral Pathol Med. 1991; 20: 332-336
        • Navazesh M
        • Wood GJ
        • Brightman VJ.
        Relationship between salivary flow rates and Candida albicans counts.
        Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995; 80: 284-288
        • Navazesh M
        • Mulligan R
        • Komaroff E
        • Redford M
        • Greenspan D
        • Phelan JA.
        The prevalence of xerostomia and salivary gland hypofunction in a cohort of HIV-positive and at-risk women.
        J Dent Res. 2000; 79: 15027
        • Larmas M
        • Makinen KK
        • Scheinin A.
        Turku sugar studies. III. An intermediate report on the effect of sucrose, fructose and xylitol diets on the numbers of salivary lactobacilli, Candida and streptococci.
        Acta Odontol Scand. 1974; 32: 423-433
        • Olsen I.
        Denture stomatitis. Occurrence and distribution of fungi.
        Acta Odontol Scand. 1974; 32: 329-333
        • Budtz-Jorgensen E
        • Thylstrup A.
        The effect of controlled oral hygiene in overdenture wearers.
        Acta Odontol Scand. 1988; 46: 219-225
        • Jacob LS
        • Flaitz CM
        • Nichols CM
        • Hicks MJ.
        Role of dentinal carious lesions in the pathogenesis of oral candidiasis in HIV infection.
        J Am Dent Assoc. 1998; 129: 187-194
        • Eversole LR
        • Reichart PA
        • Ficarra G
        • Schmidt-Westhausen A
        • Romagnoli P
        • Pimpinelli N.
        Oral keratinocyte immune responses in HIV-associated candidiasis.
        Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997; 84: 372-380
        • Reichart PA
        • Samaranayake LP
        • Philipsen HP.
        Pathology and clinical correlates in oral candidiasis and its variants: a review.
        Oral Dis. 2000; 6: 85-91